SCHEMBL7217066

SCHEMBL7217066

O=C(Nc1ccn(CCN2CCC2)n1)c1c[nH]c2c1-c1ncccc1CCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 1/20 0.40
IGF1R P08069 6/20 0.34
NPSR1 Q6W5P4 1/20 0.33
RET P07949 2/20 0.32
KDR P35968 2/20 0.32
JAK2 O60674 1/20 0.32
OPRM1 P35372 2/20 0.32
OPRD1 P41143 2/20 0.32
OPRK1 P41145 2/20 0.32
HDAC1 Q13547 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
BUB1 O43683 1/20 0.32
MET P08581 1/20 0.31
HRH1 P35367 1/20 0.31
KCNH2 Q12809 1/20 0.31
MAPK1 P28482 1/20 0.31
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7218419 0.98 GCK (0.40) GCKIGF1RNPSR1RETKDR
SCHEMBL7216130 0.95 GCK (0.36) GCKIGF1RNPSR1CHRM2CHRM4
SCHEMBL7223214 0.91 NPSR1 (0.34) GCKIGF1RNPSR1RETKDR
SCHEMBL7222958 0.88 NPSR1 (0.34) GCKNPSR1CHRM2CHRM4CHRM1
SCHEMBL7222707 0.87 GCK (0.34) GCKNPSR1RETKDRCHRM2
SCHEMBL7218239 0.86 GCK (0.33) GCKNPSR1CHRM2CHRM4CHRM1
SCHEMBL7218337 0.86 GCK (0.33) GCKNPSR1RETKDRCHRM2
SCHEMBL7218258 0.86 GCK (0.33) GCKNPSR1CHRM2CHRM4CHRM1
SCHEMBL7223193 0.86 PIM1 (0.32) GCKNPSR1
SCHEMBL7223026 0.85 GCK (0.33) GCKNPSR1CHRM2CHRM4CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653471-B2 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction NEUROGEN CORPORATION 2003-11-25 US disclosed